Annexon Biosciences
Developing complement medicines
Neurodegeneration
Autoimmune
Ophthalmology
About Annexon Biosciences
Annexon Biosciences (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company focused on developing complement medicines for autoimmune, neurodegenerative, and ophthalmic disorders. The company’s innovative pipeline includes ANX005, ANX007, and ANX009, targeting the classical complement pathway. Annexon employs a biomarker-driven strategy to enhance the success of its portfolio.
Jobs at Annexon Biosciences (1)
- $272k-$302k
- United States